Stock Price
13.20
Daily Change
-0.46 -3.37%
Monthly
35.25%
Yearly
-48.44%
Q2 Forecast
13.35

Telix Pharmaceuticals reported AUD1.37M in Interest Income for its fiscal semester ending in June of 2024.





Interest Income Change Date
Cochlear AUD 7.4M 2.2M Dec/2024
CSL USD 18M 1000K Dec/2024
Integral Diagnostics AUD 482K 103K Jun/2024
Medical Developments International AUD 174K 31K Dec/2024
Mesoblast USD 921K 18K Jun/2024
Pacific Edge NZD 1.19M 348K Sep/2024
ResMed USD 59K 4K Jun/2021